Addus HomeCare (NASDAQ:ADUS) Now Covered by Macquarie

Macquarie began coverage on shares of Addus HomeCare (NASDAQ:ADUSGet Free Report) in a research note issued on Friday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $136.00 price target on the stock. Macquarie’s target price would suggest a potential upside of 17.13% from the company’s current price.

ADUS has been the subject of several other reports. Stephens upped their target price on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research note on Friday, May 31st. Oppenheimer upped their target price on shares of Addus HomeCare from $118.00 to $130.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. StockNews.com cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Friday, June 21st. Bank of America increased their price objective on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Finally, TD Cowen increased their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the company a “buy” rating in a research note on Tuesday, June 18th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $116.25.

Check Out Our Latest Stock Analysis on ADUS

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $116.11 on Friday. The firm has a fifty day simple moving average of $109.70 and a 200-day simple moving average of $99.95. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $120.53. The stock has a market capitalization of $1.90 billion, a price-to-earnings ratio of 28.81, a PEG ratio of 1.75 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. The firm had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS. On average, sell-side analysts expect that Addus HomeCare will post 4.36 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 4.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Large investors have recently made changes to their positions in the company. Louisiana State Employees Retirement System bought a new stake in shares of Addus HomeCare in the 4th quarter worth about $752,000. Dean Capital Management bought a new stake in Addus HomeCare during the 4th quarter worth about $652,000. Allianz Asset Management GmbH bought a new stake in Addus HomeCare during the 4th quarter worth about $5,667,000. Cetera Trust Company N.A bought a new stake in Addus HomeCare during the 4th quarter worth about $219,000. Finally, Vanguard Group Inc. grew its holdings in Addus HomeCare by 4.9% during the 3rd quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after acquiring an additional 57,040 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.